Cargando…
An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9
BACKGROUND: Breast cancer is highly heterogeneous, suggesting that small but relevant subsets have been under-recognized. Rare and mainly triple-negative breast cancers (TNBCs) were recently found to exhibit tuft cell-like expression profiles, including POU2F3, the tuft cell master regulator. In add...
Autores principales: | Yamada, Yosuke, Simon, Ronald, Iwane, Kosuke, Nakanishi, Yuki, Takeuchi, Yasuhide, Yoshizawa, Akihiko, Takada, Masahiro, Toi, Masakazu, Haga, Hironori, Marx, Alexander, Sauter, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183142/ https://www.ncbi.nlm.nih.gov/pubmed/37179317 http://dx.doi.org/10.1186/s12885-023-10949-5 |
Ejemplares similares
-
TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
por: Liu, Weiguang, et al.
Publicado: (2019) -
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
por: Suzuki, Eiji, et al.
Publicado: (2015) -
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
por: Yamada, Yosuke, et al.
Publicado: (2022) -
Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation
por: Hirata, Kimiko, et al.
Publicado: (2017) -
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR
por: Ueno, Takayuki, et al.
Publicado: (2022)